Measurement and Evaluations in Cancer Care

Measurement and Evaluations in Cancer Care advances the science and practice of how we measure outcomes across the cancer continuum—linking clinical, physiological, psychosocial, and patient reported data to deliver actionable insights for research, care, and education, with a global perspective. We publish original research and reviews that develop, evaluate, and implement rigorous measures and analytics relevant to oncology. Our audience includes cancer care researchers, clinicians using assessments, and methodologists focused on measurement sciences.

1. Psychometrics in Cancer Care
We welcome studies that design, refine, and test instruments for symptoms, function, quality of life, experiences, and preferences—using classical test theory, IRT/modern psychometrics, and multi method validation. Priority areas include cross cultural adaptation, measurement invariance, and interpretation frameworks that ensure comparability across languages and settings.

2. Digital Health Measurement
We invite work on wearables, smartphone sensors, remote monitoring, digital biomarkers, and AI enabled assessments that capture real world trajectories of symptoms and function. Submissions should address usability, equity, data quality, and clinical integration within oncology services and trials.

3. Biomarker–PRO Integration
We encourage studies that fuse molecular, imaging, physiological, and omics biomarkers with PROs to create multidimensional and mechanistically informed endpoints, including composite measures, predictive modelling, and data fusion approaches for precision oncology.

4. Implementation Science of Measurement Tools
We prioritize evaluations of adoption, feasibility, fidelity, workflow fit, and sustainability of instruments in routine care—spanning pragmatic trials, mixed methods, and policy relevant evaluations (eg, how measurement improves care pathways, coordination, and outcomes).

5. Methodology & Analytics
We feature state of the art statistical and methodological work—from factor analysis and IRT to responsiveness, sensitivity/specificity, minimal important difference, and longitudinal modelling—that underpins accurate, reliable, and interpretable measurement in oncology.

6. Scope Across Outcomes and Settings
Content spans physiological measures, psychosocial assessments, and PROs across prevention, treatment, survivorship, and palliative care, with attention to diverse cultures and health systems. We particularly value studies that demonstrate real world utility in clinical practice, research, or education.